This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Zu, K. Articles by Ip, C. Search for Related Content PubMed PubMed Citation Articles by Zu, K. Articles by Ip, C.

Synergy between Selenium and Vitamin E in Apoptosis Induction Is Associated with Activation of Distinctive Initiator Caspases in Human Prostate Cancer Cells¹

Department of Cancer Chemoprevention, Roswell Park Cancer Institute, Buffalo, New York 14263

The ongoing Selenium and Vitamin E Chemoprevention Trial is designed to evaluate the efficacy of these two agents, either individually or in combination, in reducing the incidence of prostate cancer in healthy men over 55 years of age. Little information, however, is available on the potential synergy between vitamin E and selenium in chemoprevention. The present study was aimed at addressing this gap of knowledge with the use of the androgen-unresponsive, p53-null, PC-3 human prostate cancer cell line. The growth-inhibitory activity of vitamin E appeared to be dependent on the chemical form. In our hands, D--tocopheryl succinate (VES) was much more potent than either DL--tocopherol or D--tocopheryl acetate. Combining VES with methylseleninic acid (MSA), a selenium metabolite, produced a synergistic effect on cell growth suppression. The synergy was accounted for primarily by an augmented apoptotic response. Poly(ADP-ribose) polymerase cleavage and activation of specific caspases were confirmed by Western blot analysis. The caspases that were commonly modulated by either VES or MSA included initiator caspases-8 and -10, as well as executioner caspases-3, -6, and -7. In contrast, caspase-9 was activated only by VES, whereas caspases-1 and -12 were activated only by MSA. Based on the above information, it is proposed that the mitochondrial pathway and the endoplasmic reticulum stress/cytokine signaling pathway might be involved in apoptosis induction by VES and MSA, respectively. These two pathways may act in a cooperative manner to switch on the full force of the apoptotic machinery when cells are treated with both VES and MSA.

This article has been cited by other articles:

				M. Katzenellenbogen, L. Mizrahi, O. Pappo, N. Klopstock, D. Olam, H. Barash, E. Domany, E. Galun, and D. Goldenberg Molecular mechanisms of the chemopreventive effect on hepatocellular carcinoma development in Mdr2 knockout mice Mol. Cancer Ther., April 1, 2007; 6(4): 1283 - 1291. [Abstract] [Full Text] [PDF]

				C. D. Davis Nutritional Interactions: Credentialing of Molecular Targets for Cancer Prevention Experimental Biology and Medicine, February 1, 2007; 232(2): 176 - 183. [Abstract] [Full Text] [PDF]

				U. Peters, C. B Foster, N. Chatterjee, A. Schatzkin, D. Reding, G. L Andriole, E D. Crawford, S. Sturup, S. J Chanock, and R. B Hayes Serum selenium and risk of prostate cancer--a nested case-control study Am. J. Clinical Nutrition, January 1, 2007; 85(1): 209 - 217. [Abstract] [Full Text] [PDF]

				E. Lee, M.-K. Choi, Y.-J. Lee, J.-L. Ku, K.-H. Kim, J.-S. Choi, and S.-J. Lim Alpha-tocopheryl succinate, in contrast to alpha-tocopherol and alpha-tocopheryl acetate, inhibits prostaglandin E2 production in human lung epithelial cells Carcinogenesis, November 1, 2006; 27(11): 2308 - 2315. [Abstract] [Full Text] [PDF]

				J. Ni, X. Wen, J. Yao, H.-C. Chang, Y. Yin, M. Zhang, S. Xie, M. Chen, B. Simons, P. Chang, et al. Tocopherol-Associated Protein Suppresses Prostate Cancer Cell Growth by Inhibition of the Phosphoinositide 3-Kinase Pathway Cancer Res., November 1, 2005; 65(21): 9807 - 9816. [Abstract] [Full Text] [PDF]

				Y. Wu, H. Zhang, Y. Dong, Y.-M. Park, and C. Ip Endoplasmic Reticulum Stress Signal Mediators Are Targets of Selenium Action Cancer Res., October 1, 2005; 65(19): 9073 - 9079. [Abstract] [Full Text] [PDF]

				Y. Dong, H. Zhang, A. C. Gao, J. R. Marshall, and C. Ip Androgen receptor signaling intensity is a key factor in determining the sensitivity of prostate cancer cells to selenium inhibition of growth and cancer-specific biomarkers Mol. Cancer Ther., July 1, 2005; 4(7): 1047 - 1055. [Abstract] [Full Text] [PDF]

				S. M. Lippman, P. J. Goodman, E. A. Klein, H. L. Parnes, I. M. Thompson, A. R. Kristal, R. M. Santella, J. L. Probstfield, C. M. Moinpour, D. Albanes, et al. Designing the Selenium and Vitamin E Cancer Prevention Trial (SELECT) J Natl Cancer Inst, January 19, 2005; 97(2): 94 - 102. [Abstract] [Full Text] [PDF]

				K. Zu, L. Hawthorn, and C. Ip Up-regulation of c-Jun-NH2-kinase pathway contributes to the induction of mitochondria-mediated apoptosis by {alpha}-tocopheryl succinate in human prostate cancer cells Mol. Cancer Ther., January 1, 2005; 4(1): 43 - 50. [Abstract] [Full Text] [PDF]

				Y. Dong, S. O. Lee, H. Zhang, J. Marshall, A. C. Gao, and C. Ip Prostate Specific Antigen Expression Is Down-Regulated by Selenium through Disruption of Androgen Receptor Signaling Cancer Res., January 1, 2004; 64(1): 19 - 22. [Abstract] [Full Text] [PDF]